N'-((2S,3S)-2-(Benzyloxy)pentan-3-yl)formohydrazide

Catalog No. :
ACYLZW817
CAS No. :
170985-85-0
Molecular Formula :
C13H20N2O2
Molecular Weight :
236.32

IUPAC Name:N'-((2S,3S)-2-(benzyloxy)pentan-3-yl)formohydrazide

N'-((2S,3S)-2-(Benzyloxy)pentan-3-yl)formohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$168.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN'-((2S,3S)-2-(Benzyloxy)pentan-3-yl)formohydrazide
IUPAC NameN'-((2S,3S)-2-(benzyloxy)pentan-3-yl)formohydrazide
MDL No.MFCD11977289
Molecular FormulaC13H20N2O2
Molecular Weight236.32
SMILESO=CNN[C@@H](CC)[C@@H](OCC1=CC=CC=C1)C
InChI KeyLNEGZKZTVLXZFX-AAEUAGOBSA-N
Synonym[S-(R*,R*)]-2-[1-Ethyl-2-(phenylMethoxy)propyl]hydrazinecarboxaldehyde;Posaconazole int;Posaconazole Impurity 15 Oxalate;Formic acid N'-(2(S)-benzyloxy-1(S)-ethyl-propyl)-hydrazide;N'-((2S,3S);pentan-3-yl);N-[[(2S,3S)-2-phenylmethoxypentan-3-yl]amino]formamide;2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazinecarboxaldehyde
CAS No.170985-85-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACYLZW817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2 In Stock
  4. Then
  5. ACYLZW817 route product structure diagram
    ACYLZW817170985-85-0
Inquiry

2. ACYLZW817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEDMW612 route compound structure diagram
    ACEDMW6126108-23-2 In Stock
  4. Then
  5. ACYLZW817 route product structure diagram
    ACYLZW817170985-85-0
Inquiry

Comments (0)